{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:44:17Z","timestamp":1771263857648,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>While prior research has provided important information about readmission rates following percutaneous coronary intervention, reports regarding charges and length of stay for readmission beyond 30\u2009days post-discharge for patients in a large cohort are limited. The objective of this study was to characterize the rehospitalization of patients with acute coronary syndrome receiving percutaneous coronary intervention in a U.S. health benefit plan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study retrospectively analyzed administrative claims data from a large US managed care plan at index hospitalization, 30-days, and 31-days to 15-months rehospitalization. A valid Diagnosis Related Group code (version 24) associated with a PCI claim (codes 00.66, 36.0X, 929.73, 929.75, 929.78\u2013929.82, 929.84, 929.95\/6, and G0290\/1) was required to be included in the study. Patients were also required to have an ACS diagnosis on the day of admission or within 30\u2009days prior to the index PCI. ACS diagnoses were classified by the International Statistical Classification of Disease 9 (ICD-9-CM) codes 410.xx or 411.11. Patients with a history of transient ischemic attack or stroke were excluded from the study because of the focus only on ACS-PCI patients. A clopidogrel prescription claim was required within 60\u2009days after hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 6,687 ACS-PCI patients included in the study, 5,174 (77.4%) were male, 5,587 (83.6%) were &lt;65\u2009years old, 4,821 (72.1%) had hypertension, 5,176 (77.4%) had hyperlipidemia, and 1,777 (26.6%) had diabetes. At index hospitalization drug-eluting stents were the most frequently used: 5,534 (82.8%). Of the 4,384 patients who completed the 15-month follow-up, a total of 1,367 (31.2%) patients were rehospitalized for cardiovascular (CV)-related events, of which 811 (59.3%) were revascularization procedures: 13 (1.0%) for coronary artery bypass graft and 798 (58.4%) for PCI. In general, rehospitalizations associated with revascularization procedures cost more than other CV-related rehospitalizations. Patients rehospitalized for revascularization procedures had the shortest median time from post-index PCI to rehospitalization when compared to the patients who were rehospitalized for other CV-related events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>For ACS patients who underwent PCI, revascularization procedures represented a large portion of rehospitalizations. Revascularization procedures appear to be the most frequent, most costly, and earliest cause for rehospitalization after ACS-PCI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-5-342","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T14:15:36Z","timestamp":1341238536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis"],"prefix":"10.1186","volume":"5","author":[{"given":"Eric S","family":"Meadows","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay P","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darell","family":"Heiselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,2]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams R, Brown TM, Carthenon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, et al: Heart disease and stroke statistics \u2013 2010 update: a report from the American Heart Association. Circulation. 2010, 121: e46-e215.","journal-title":"Circulation"},{"key":"1727_CR2","first-page":"S430","volume":"12","author":"AG Turpie","year":"2006","unstructured":"Turpie AG: Burden of disease: medical and economic impact of acute coronary syndromes. Am J Manag Care. 2006, 12: S430-S434.","journal-title":"Am J Manag Care"},{"key":"1727_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00019053-200321160-00001","volume":"21","author":"N Bosanquet","year":"2003","unstructured":"Bosanquet N, Jonsson B, Fox KA: Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb\/IIIa inhibitors: in the management of acute coronary syndromes. Pharacoeconomics. 2003, 21: 1135-1152. 10.2165\/00019053-200321160-00001.","journal-title":"Pharacoeconomics"},{"key":"1727_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2004.08.042","volume":"100","author":"S Palmer","year":"2005","unstructured":"Palmer S, Sculpher M, Phillips Z, Robinson M, Ginnelly L, Bakhai A, Abrams K, Cooper N, Packham C, Alfakih K, Hall A, Gray D: Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb\/IIIa antagonists in the UK National Health Service?. Int J Cardiol. 2005, 100: 229-240. 10.1016\/j.ijcard.2004.08.042.","journal-title":"Int J Cardiol"},{"key":"1727_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/euhj.1999.1995","volume":"21","author":"J Collinson","year":"2000","unstructured":"Collinson J, Flather MD, Fox KA, Findlay I, Rodrigues E, Dooley P, Ludman P, Adgey J, Bowker TJ, Mattu R, for the PRAIS-UK Investigators: Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J. 2000, 21: 1450-1457. 10.1053\/euhj.1999.1995.","journal-title":"Eur Heart J"},{"key":"1727_CR6","volume-title":"Heart & Stroke Encyclopedia","author":"American Heart Association","year":"2011","unstructured":"American Heart Association: Heart & Stroke Encyclopedia. 2011, Percutaneous coronary intervention (PCI) and PCI-capable hospital [http:\/\/www.americanheart.org\/presenter.jhtml?identifier\u2009=\u20093061532]"},{"key":"1727_CR7","volume-title":"Candidate hospital care additional priorities: 2007 performance measure","author":"National Quality Forum","year":"2007","unstructured":"National Quality Forum: Candidate hospital care additional priorities: 2007 performance measure. 2007, National Quality Forum, Washington, DC"},{"key":"1727_CR8","first-page":"23673","volume":"73","author":"Centers for Medicare and Medicaid Services","year":"2008","unstructured":"Centers for Medicare and Medicaid Services: Application of incentives to reduce avoidable readmissions to hospitals. Fed Regist. 2008, 73: 23673-23675.","journal-title":"Fed Regist"},{"key":"1727_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1185\/030079908X261096","volume":"24","author":"J Menzin","year":"2008","unstructured":"Menzin J, Wygant G, Hauch O, Jackel J, Friedman M: One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin. 2008, 24: 461-468. 10.1185\/030079908X261096.","journal-title":"Curr Med Res Opin"},{"key":"1727_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jacc.2009.04.076","volume":"54","author":"JP Curtis","year":"2009","unstructured":"Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM: All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol. 2009, 54: 903-907. 10.1016\/j.jacc.2009.04.076.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009, 360: 1418-1428. 10.1056\/NEJMsa0803563.","journal-title":"N Engl J Med"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","volume":"113","author":"JA Spertus","year":"2006","unstructured":"Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rusfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ: Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement. Circulation. 2006, 113: 2803-2809. 10.1161\/CIRCULATIONAHA.106.618066.","journal-title":"Circulation"},{"key":"1727_CR13","volume-title":"Analysis of clopidogrel use in outpatient settings","author":"JP Bae","year":"2007","unstructured":"Bae JP, Bellebaum KL, McCollam PL: Analysis of clopidogrel use in outpatient settings. 2007, Arlington, VA, Presented at: 12th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) International Meeting, May 19\u201323"},{"key":"1727_CR14","volume-title":"Impact of including prasugrel on the formulary for patients who undergo percutaneous coronary intervention for acute coronary syndrome","author":"J Mauskopf","year":"2009","unstructured":"Mauskopf J, Graham JB, Bae J, Gaich C: Impact of including prasugrel on the formulary for patients who undergo percutaneous coronary intervention for acute coronary syndrome. 2009, Paris, France, Presented at: 12th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress, October 24\u201327"},{"key":"1727_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/hrt.2005.084830","volume":"93","author":"KA Fox","year":"2007","unstructured":"Fox KA, Anderson FA, Dabbous OH, Steg PG, Lopez-Sendon J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D, for the GRACE Investigators: Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007, 93: 177-182.","journal-title":"Heart"},{"key":"1727_CR16","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"CP Cannon","year":"2001","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E, for the TACTICS\u2014Thrombolysis in Myocardial Infarction 18 Investigators: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med. 2001, 344: 1879-1887. 10.1056\/NEJM200106213442501.","journal-title":"N Engl J Med"},{"key":"1727_CR17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0195-668X(03)00211-2","volume":"24","author":"A Prasad","year":"2003","unstructured":"Prasad A, Mathew V, Holmes DR, Gersh BJ: Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur Heart J. 2003, 24: 1544-1553. 10.1016\/S0195-668X(03)00211-2.","journal-title":"Eur Heart J"},{"key":"1727_CR18","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","volume":"23","author":"ME Bertrand","year":"2002","unstructured":"Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, De Feyter PJ, Specchia G, Ruzyllo W: Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002, 23: 1809-1840. 10.1053\/euhj.2002.3385.","journal-title":"Eur Heart J"},{"key":"1727_CR19","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"E Braunwald","year":"2002","unstructured":"Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith CC: ACC\/AHA 2002 guideline update for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction\u2014summary article: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002, 40: 1366-1374. 10.1016\/S0735-1097(02)02336-7.","journal-title":"J Am Coll Cardiol"},{"key":"1727_CR20","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1185\/03007990903333017","volume":"25","author":"B Chastek","year":"2009","unstructured":"Chastek B, Riedel AA, Wygant G, Hauch O: Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel. Curr Med Res Opin. 2009, 25: 2845-2852. 10.1185\/03007990903333017.","journal-title":"Curr Med Res Opin"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:21:47Z","timestamp":1630527707000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-342","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,2]]},"assertion":[{"value":"21 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"342"}}